![David J. Wustrow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David J. Wustrow
Plus aucun poste en cours
Profil
David J.
Wustrow worked at Pfizer NV as Senior Director-Neuroscience Chemistry from 1989 to 2006.
He worked at Pfizer Inc. as Senior Director-Neuroscience Chemistry from 2003 to 2005.
He worked at Neurogen Technologies, Inc. as Executive Director-Chemistry from 2005 to 2008.
He worked at XenoPort, Inc. as Executive Director-Scientific Assessment from 2011 to 2012.
He worked at Neurogen Corp.
as Executive Director-Chemistry from 2012 to 2014.
He worked at Cleave Therapeutics, Inc. as VP-Chemistry & Pharmaceutical Sciences from 2012 to 2016.
He worked at Rapt Therapeutics, Inc. as Senior VP-Drug Discovery & Preclinical Development from 2019 to 2026.
Education includes a doctorate from Rochester Christian University and an undergraduate degree from The Pennsylvania State University.
Anciens postes connus de David J. Wustrow
| Sociétés | Poste | Fin |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Corporate Officer/Principal | 03/03/2026 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Corporate Officer/Principal | 01/02/2016 |
| XENOPORT, INC. | Corporate Officer/Principal | 01/01/2012 |
Neurogen Technologies, Inc. | Corporate Officer/Principal | 01/01/2008 |
Pfizer NV/SA
 Pfizer NV/SA Financial ConglomeratesFinance Provides investment, development and production services in biomedical research | Corporate Officer/Principal | 01/10/2006 |
Formation de David J. Wustrow
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer NV/SA
Pfizer NV/SA Financial ConglomeratesFinance Provides investment, development and production services in biomedical research | Finance |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
Neurogen Technologies, Inc. |
